Li, Yan
Hall, Trevor
Razak, Fahad
Verma, Amol
Chignell, Mark
Wang, Lu
Funding for this research was provided by:
Canadian Institutes of Health Research
The U.S. National Science Foundation
Article History
Received: 15 October 2024
Accepted: 6 May 2025
First Online: 22 May 2025
Declarations
:
: The Institutional Review Board (IRB) at the University of Toronto (Health Sciences Committee) approved the GEMINI study (protocol number 38377) and associated secondary data analysis such as the analyses reported in this paper. The requirement to collect informed consent was waived by the IRB as reflected in the approved protocol. The protocol under which this study was run adhered to the Declaration of Helsinki, whose policies are reflected in the operation of the University of Toronto IRB and which guided the approval of the GEMINI study protocol.
: This article does not contain any studies with identifiable human participants or animals, and no consent for publication was required.
: The authors declare no competing interests.